gemcitabine has been researched along with niclosamide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Easwaran, M; Manickam, M; Pillaiyar, T; Wendt, LL | 1 |
| Bai, Y; Guo, H; Guo, Y; Huang, Y; Lin, M; Xiao, Y; Yang, X; Yuan, Z; Zhang, Q; Zhu, H | 1 |
| Fang, S; Kang, HW; Kim, HJ; Kim, HS; Kim, JH; Kim, MJ; Lee, BE; Lee, DE; Lee, KJ; Lee, YS; Park, JS; Yoo, J | 1 |
1 review(s) available for gemcitabine and niclosamide
| Article | Year |
|---|---|
The recent outbreaks of human coronaviruses: A medicinal chemistry perspective.
Topics: Antiviral Agents; Chemistry, Pharmaceutical; COVID-19; Disease Outbreaks; Drug Repositioning; Humans; Virus Internalization | 2021 |
2 other study(ies) available for gemcitabine and niclosamide
| Article | Year |
|---|---|
The anthelmintic drug niclosamide induces GSK-β-mediated β-catenin degradation to potentiate gemcitabine activity, reduce immune evasion ability and suppress pancreatic cancer progression.
Topics: Animals; Anthelmintics; beta Catenin; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Gemcitabine; Glycogen Synthase Kinase 3 beta; Humans; Immune Evasion; Mice; Niclosamide; Pancreatic Neoplasms; Wnt Signaling Pathway | 2022 |
Combination therapy of niclosamide with gemcitabine inhibited cell proliferation and apoptosis via Wnt/β-catenin/c-Myc signaling pathway by inducing β-catenin ubiquitination in pancreatic cancer.
Topics: Apoptosis; beta Catenin; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferation; Gemcitabine; Humans; Niclosamide; Pancreatic Neoplasms; Proto-Oncogene Proteins c-myc; Ubiquitination; Wnt Signaling Pathway | 2023 |